Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.08
+0.08 (0.73%)
At close: Jun 3, 2026, 4:00 PM EDT
10.86
-0.22 (-1.99%)
After-hours: Jun 3, 2026, 4:29 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $159.8 million as of June 3, 2026. Its market cap has increased by 12.62% in one year.
Market Cap
159.80M
Enterprise Value
37.27M
1-Year Change
12.62%
Ranking
Category
Stock Price
$11.08
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $159.80M, an increase of 29.08%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 158.65M | 110.32% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 171.18M |
| Innate Pharma | 171.10M |
| OnKure Therapeutics | 170.47M |
| NRx Pharmaceuticals | 167.23M |
| Spero Therapeutics | 163.86M |
| Precision BioSciences | 163.07M |
| Jyong Biotech | 160.34M |
| Protalix BioTherapeutics | 160.34M |